Search research articles
Contact Us
Filters
Showing results (1-10 of 42) with videos related to
Page
of 5
Sort By:
Current Opinion in Molecular Therapeutics
|
October 2, 2010
Gene therapy for Parkinson's disease: from non-human primates to humans
Massimo S Fiandaca, Krystof S Bankiewicz
Experimental Neurology
|
March 26, 2013
Using viral-mediated gene delivery to model Parkinson's disease: do nonhuman primate investigations expand our understanding?
Massimo S Fiandaca, Howard J Federoff
Journal of Parkinson'S Disease
|
May 6, 2026
Clinical GDNF delivery methods for Parkinson's disease
Matthias Luz, Massimo S Fiandaca, Krystof S Bankiewicz
Toxins
|
November 10, 2011
The use of convection-enhanced delivery with liposomal toxins in neurooncology
Massimo S Fiandaca, Mitchel S Berger, Krystof S Bankiewicz
Pharmaceuticals (Basel, Switzerland)
|
November 28, 2013
Gene therapy for the treatment of Parkinson's disease: the nature of the biologics expands the future indications
Massimo S Fiandaca, Krystof S Bankiewicz, Howard J Federoff
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
January 1, 2008
Image-guided convection-enhanced delivery platform in the treatment of neurological diseases
Massimo S Fiandaca, John R Forsayeth, Peter J Dickinson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 14, 2014
The critical need for defining preclinical biomarkers in Alzheimer's disease
Massimo S Fiandaca, Mark E Mapstone, Amrita K Cheema, et al.
International Journal of Molecular Sciences
|
November 15, 2018
Fetal Bovine Serum-Derived Extracellular Vesicles Persist within Vesicle-Depleted Culture Media
Brandon M Lehrich, Yaxuan Liang, Pooya Khosravi, et al.
Journal of Alzheimer'S Disease : JAD
|
August 16, 2021
Plasma Sphingomyelins in Late-Onset Alzheimer's Disease
Gianna Fote, Jie Wu, Mark Mapstone, et al.
Neurologia I Neurochirurgia Polska
|
June 20, 2020
Advancing gene therapies, methods, and technologies for Parkinson's Disease and other neurological disorders
Massimo S Fiandaca, Russell R Lonser, J Bradley Elder, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 42) with videos related to
Sort By:
Page
of 5
Current Opinion in Molecular Therapeutics
|
October 2, 2010
Gene therapy for Parkinson's disease: from non-human primates to humans
Massimo S Fiandaca, Krystof S Bankiewicz
Experimental Neurology
|
March 26, 2013
Using viral-mediated gene delivery to model Parkinson's disease: do nonhuman primate investigations expand our understanding?
Massimo S Fiandaca, Howard J Federoff
Journal of Parkinson'S Disease
|
May 6, 2026
Clinical GDNF delivery methods for Parkinson's disease
Matthias Luz, Massimo S Fiandaca, Krystof S Bankiewicz
Toxins
|
November 10, 2011
The use of convection-enhanced delivery with liposomal toxins in neurooncology
Massimo S Fiandaca, Mitchel S Berger, Krystof S Bankiewicz
Pharmaceuticals (Basel, Switzerland)
|
November 28, 2013
Gene therapy for the treatment of Parkinson's disease: the nature of the biologics expands the future indications
Massimo S Fiandaca, Krystof S Bankiewicz, Howard J Federoff
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
January 1, 2008
Image-guided convection-enhanced delivery platform in the treatment of neurological diseases
Massimo S Fiandaca, John R Forsayeth, Peter J Dickinson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 14, 2014
The critical need for defining preclinical biomarkers in Alzheimer's disease
Massimo S Fiandaca, Mark E Mapstone, Amrita K Cheema, et al.
International Journal of Molecular Sciences
|
November 15, 2018
Fetal Bovine Serum-Derived Extracellular Vesicles Persist within Vesicle-Depleted Culture Media
Brandon M Lehrich, Yaxuan Liang, Pooya Khosravi, et al.
Journal of Alzheimer'S Disease : JAD
|
August 16, 2021
Plasma Sphingomyelins in Late-Onset Alzheimer's Disease
Gianna Fote, Jie Wu, Mark Mapstone, et al.
Neurologia I Neurochirurgia Polska
|
June 20, 2020
Advancing gene therapies, methods, and technologies for Parkinson's Disease and other neurological disorders
Massimo S Fiandaca, Russell R Lonser, J Bradley Elder, et al.
Page
of 5